Takeda Pharmaceutical (TAK) Projected to Post Quarterly Earnings on Thursday

Takeda Pharmaceutical (NYSE:TAK) will likely be issuing its quarterly earnings data before the market opens on Thursday, February 6th. Analysts expect the company to announce earnings of $0.34 per share for the quarter. Persons that wish to register for the company’s earnings conference call can do so using this link.

Takeda Pharmaceutical Price Performance

NYSE:TAK opened at $13.35 on Thursday. Takeda Pharmaceutical has a 1-year low of $12.57 and a 1-year high of $15.08. The company has a current ratio of 1.28, a quick ratio of 0.77 and a debt-to-equity ratio of 0.64. The firm has a fifty day simple moving average of $13.30 and a 200 day simple moving average of $13.89. The stock has a market capitalization of $42.46 billion, a PE ratio of 23.01, a P/E/G ratio of 0.24 and a beta of 0.51.

Takeda Pharmaceutical Company Profile

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, immunology, oncology, and neuroscience.